Reversed-phase high-performance liquid chromatographic determination of anaxirone in biological specimens. 1986

R B Schilcher, and J D Young, and M R Nowrousian, and B Hoffmann, and C G Schmidt

UI MeSH Term Description Entries
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole

Related Publications

R B Schilcher, and J D Young, and M R Nowrousian, and B Hoffmann, and C G Schmidt
January 1985, Journal of analytical toxicology,
R B Schilcher, and J D Young, and M R Nowrousian, and B Hoffmann, and C G Schmidt
January 1987, Journal of chromatography,
R B Schilcher, and J D Young, and M R Nowrousian, and B Hoffmann, and C G Schmidt
July 1997, Se pu = Chinese journal of chromatography,
R B Schilcher, and J D Young, and M R Nowrousian, and B Hoffmann, and C G Schmidt
January 1980, Chemical & pharmaceutical bulletin,
R B Schilcher, and J D Young, and M R Nowrousian, and B Hoffmann, and C G Schmidt
October 1986, Journal of chromatography,
R B Schilcher, and J D Young, and M R Nowrousian, and B Hoffmann, and C G Schmidt
May 1994, Journal of chromatography. B, Biomedical applications,
R B Schilcher, and J D Young, and M R Nowrousian, and B Hoffmann, and C G Schmidt
February 1984, Journal of chromatography,
R B Schilcher, and J D Young, and M R Nowrousian, and B Hoffmann, and C G Schmidt
December 1991, The Analyst,
R B Schilcher, and J D Young, and M R Nowrousian, and B Hoffmann, and C G Schmidt
January 1985, Therapeutic drug monitoring,
R B Schilcher, and J D Young, and M R Nowrousian, and B Hoffmann, and C G Schmidt
May 1999, Se pu = Chinese journal of chromatography,
Copied contents to your clipboard!